APA (7th ed.) Citation

MS, E., ED, S., P, D., & VM, K. (2019). Beyond the Label: Ensuring That Drug Benefits Outweigh Risks in the Food and Drug Administration's Risk Evaluation and Mitigation Strategy Program. The American journal of gastroenterology, 114(7), 1017. https://doi.org/10.14309/ajg.0000000000000215

Chicago Style (17th ed.) Citation

MS, Epstein, Shah ED, Deepak P, and Kushnir VM. "Beyond the Label: Ensuring That Drug Benefits Outweigh Risks in the Food and Drug Administration's Risk Evaluation and Mitigation Strategy Program." The American Journal of Gastroenterology 114, no. 7 (2019): 1017. https://doi.org/10.14309/ajg.0000000000000215.

MLA (9th ed.) Citation

MS, Epstein, et al. "Beyond the Label: Ensuring That Drug Benefits Outweigh Risks in the Food and Drug Administration's Risk Evaluation and Mitigation Strategy Program." The American Journal of Gastroenterology, vol. 114, no. 7, 2019, p. 1017, https://doi.org/10.14309/ajg.0000000000000215.